Kazunori Nagasaka
No ORCID on file
· 9 papers in corpus
· active 2007-2025
Study types
- article 6
- case-report 1
Condition tags
- endometriosis 3
- adenomyosis 2
- chronic_pelvic_pain 1
- infertility 1
Top journals
Frequent coauthors
- Haruko Hiraike 4
- Hiraike H 4
- Yutaka Osuga 3
- Matsumoto Y 3
- Tomoyuki Fujii 3
- Terashima T 3
- Fujino T 3
- Kukita A 3
- Takuya Ayabe 3
- Eiji Ryo 2
case-report
2025
BACKGROUND: Adenomyosis, characterized by endometrial tissue within the uterine muscle, often presents with severe pelvic pain and menorrhagia. This case series demonstrates the efficacy of sequential therapy involving relugolix followed by…
article
2024
AIM: As a treatment for tubal infertility, falloposcopic tuboplasty (FT) is one of the options for patients who wish to conceive naturally. Based on the results of FT, we propose an appropriate time of transitioning to assisted reproductive…
article
2021
Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyos…
article
2021
Ulipristal acetate (UPA), a selective progesterone receptor modulator, is used for the treatment of uterine fibroids and selectively inhibits the proliferation and inflammation of leiomyoma cells. As few studies have focused on the molecula…
article
2021
2020
Previous studies have suggested that histone methylation can modulate carcinogenesis and cancer progression. For instance, the histone methyltransferase SET and MYND domain containing 2 (SMYD2) is overexpressed in several types of cancer ti…
2019
BackgroundWolf-Hirschhorn syndrome candidate gene-1 (WHSC1), a histone methyltransferase, has been found to be upregulated and its expression to be correlated with expression of enhancer of zeste homolog 2 (EZH2) in several cancers. In this…
article
2017
article
2007